Cell Organization Through Phase Separation: Mechanisms, Functions and Disease
通过相分离的细胞组织:机制、功能和疾病
基本信息
- 批准号:10666575
- 负责人:
- 金额:$ 36.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-25 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAmyotrophic Lateral SclerosisBase CompositionBiochemicalBiologicalBiological ProcessBiophysicsCarcinomaCellsChromatinClientDiseaseDrug DesignEncapsulatedEukaryotic CellEwings sarcomaFilamentFrontotemporal DementiaGene ExpressionGenetic TranscriptionGenomeGenomic SegmentHistonesHumanIndividualLeadLearningLiquid substanceMalignant NeoplasmsMembraneMicrofluidicsModelingModificationMutationNerve DegenerationNucleosomesPatternPhasePhysical condensationPlayPost-Translational Protein ProcessingProcessProtein RegionProteinsRNARNA HelicaseRNA metabolismRegulationRoleSignal TransductionSignaling MoleculeSolidTimeWorkYeastsamyloid formationexperimental studyinsightmacromoleculenovel strategiesnovel therapeutic interventionpredictive modelingprogramsscaffoldself assemblyskin barrierskin disordersmall molecule
项目摘要
Biomolecular condensates concentrate select groups of macromolecules into discrete foci in eukaryotic cells
in the absence of a surrounding membrane. Condensates are found throughout eukaryotic cells, and function
in processes ranging from signal transduction to RNA metabolism to gene expression. Aberrant condensates
have been implicated in neurodegeneration, cancer and skin diseases. Our understanding of eukaryotic cell
organization was transformed by the discovery that many condensates appear to form through liquid-liquid
phase separation (LLPS) of multivalent macromolecules. My lab played an important part in this discovery by
establishing key principles, including the essential role of multivalent interactions in promoting biological
LLPS, the regulation of LLPS by covalent modifications, and the ability of LLPS to increase enzymatic
activity. In recent years, we showed that and how LLPS can produce membrane-associated clusters that
increase the specific activity of signaling molecules. We also showed that intrinsically disordered regions of
proteins (IDRs) can undergo LLPS to produce liquid droplets that harden to solids over time, likely due to
formation of amyloid filaments, and that misregulated hardening may contribute to neurodegeneration.
Further, we proposed the first model to explain condensate composition based on a scaffold/client framework.
Most recently, we showed that chromatin has an intrinsic propensity to undergo LLPS, providing a new view
of eukaryotic genome organization. Here, we propose a broad program to address leading questions in the
biomolecular condensate field. We will use microfluidics to assess LLPS of thousands of IDRs in a single
experiment, leading to a predictive model for the sequence determinants of LLPS and amyloid formation by
IDRs. This work will deepen our biophysical understanding of these processes, predict which IDRs are likely
to contribute to specific biological processes (e.g. transcription) through self-assembly, and reveal how IDR
mutations lead to disease through amyloid formation. We will also examine how individual components of
yeast P bodies impact the LLPS threshold and composition of the compartments and how RNA helicase and
RNA decapping activities are modulated within them. This work will lead to a new model of condensate
composition based on the patterns of interaction between components, and will explain how composition and
encapsulation can control enzymatic activities in native condensates. Finally, we will learn how
internucleosome spacing and diverse histone post-translational modifications control chromatin LLPS to
generate biochemically and functionally distinct genomic regions, examine whether NUT carcinoma is caused
by defective LLPS, and develop a new approach to drug design based on targeting small molecules to
condensates. Together, the work will reveal new principles of biological phase separation, explain how phase
separation can be used to control RNA metabolism and genome organization and function, and provide insights
into the mechanisms and potential treatments of neurodegeneration and cancer.
在真核细胞中,生物分子凝聚物集中选择大分子群形成离散的病灶
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mechanistic dissection of increased enzymatic rate in a phase-separated compartment.
- DOI:10.1038/s41589-021-00801-x
- 发表时间:2021-06
- 期刊:
- 影响因子:14.8
- 作者:Peeples W;Rosen MK
- 通讯作者:Rosen MK
In diverse conditions, intrinsic chromatin condensates have liquid-like material properties.
- DOI:10.1073/pnas.2218085120
- 发表时间:2023-05-02
- 期刊:
- 影响因子:11.1
- 作者:Gibson, Bryan A.;Blaukopf, Claudia;Lou, Tracy;Chen, Lifeng;Doolittle, Lynda K.;Finkelstein, Ilya;Narlikar, Geeta J.;Gerlich, Daniel W.;Rosen, Michael K.
- 通讯作者:Rosen, Michael K.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael K Rosen其他文献
Michael K Rosen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael K Rosen', 18)}}的其他基金
Cell Organization Through Phase Separation: Mechanisms, Functions and Disease
通过相分离的细胞组织:机制、功能和疾病
- 批准号:
10494077 - 财政年份:2021
- 资助金额:
$ 36.9万 - 项目类别:
Cell Organization Through Phase Separation: Mechanisms, Functions and Disease
通过相分离的细胞组织:机制、功能和疾病
- 批准号:
10204847 - 财政年份:2021
- 资助金额:
$ 36.9万 - 项目类别:
Structure and function of Arp 2/3 complex--Subproject 2
Arp 2/3复合体的结构与功能--子项目2
- 批准号:
6769739 - 财政年份:2003
- 资助金额:
$ 36.9万 - 项目类别:
The Pathway to Activation of the Vav Proto-Oncogene
Vav 原癌基因的激活途径
- 批准号:
6848307 - 财政年份:2003
- 资助金额:
$ 36.9万 - 项目类别:
The Pathway to Activation of the Vav Proto-Oncogene
Vav 原癌基因的激活途径
- 批准号:
7010636 - 财政年份:2003
- 资助金额:
$ 36.9万 - 项目类别:
The Pathway to Activation of the Vav Proto-Oncogene
Vav 原癌基因的激活途径
- 批准号:
6560846 - 财政年份:2003
- 资助金额:
$ 36.9万 - 项目类别:
The Pathway to Activation of the Vav Proto-Oncogene
Vav 原癌基因的激活途径
- 批准号:
6699671 - 财政年份:2003
- 资助金额:
$ 36.9万 - 项目类别:
STRUCTURAL STUDY OF RHO-GTPASE REGULATORS AND EFFECTORS
RHO-GTP酶调节器和效应器的结构研究
- 批准号:
6181252 - 财政年份:1997
- 资助金额:
$ 36.9万 - 项目类别:
Structural Study of GTPase Regulators and Effectors
GTPase 调节器和效应器的结构研究
- 批准号:
7371663 - 财政年份:1997
- 资助金额:
$ 36.9万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 36.9万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 36.9万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 36.9万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 36.9万 - 项目类别:
Standard Grant
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 36.9万 - 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 36.9万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 36.9万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 36.9万 - 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 36.9万 - 项目类别:
Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 36.9万 - 项目类别:
Fellowship














{{item.name}}会员




